Recall two batches of cinac 30 mg
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer cinac 30 mg tablet CINACALCET 2305233694 23D590 & 23D589 Abdi Ibrahim Ilac San ve Tic A.S.
التصنيف
ملف
التاريخ
2025-08-24
اسم المستحضر
Cinac 30 mg
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The SFDA has issued a recall for two batches of Cinac tablets due to out-of-specification levels of the N-Nitroso Cinacalcet impurity.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。